Calendar Sienna Biopharmaceuticals, Inc.

Equities

Market Closed - OTC Markets Other stock markets 12:16:25 2024-05-10 pm EDT			5-day change	1st Jan Change
0.000001 ^USD	0.00%		0.00%	0.00%

2021	Motion for Asset Sale Approved for Sienna Biopharmaceuticals, Inc.	CI
2021	Avro Life Sciences, Inc. entered into an agreement to acquire Certain Assets of Sienna Biopharmaceuticals, Inc. (OTCPK:SNNA.Q) for $0.1 million.	CI

1fdc61a.xl_PwteTZ1idgMcn6zUOLmlys793uu40ZyjSFmW0NEY.oW-2k7vYAiHz8ZgVqXA6ShFG5_E4yNdHBmDnWiSHQRWzF46lst9XN_XrpA~ffed3443ac1edd70850facb2e812ef10

No events available

2020-10-08	Interim 2020 Earnings Release
2019-06-25 01:40 pm	BMO Prescription for Success Healthcare Conference
2019-06-15 02:00 am	World Dermatology Congress - SNA-120
2019-05-30 02:00 pm	Annual General Meeting
2019-05-23 03:30 am	Dermatology Drug Development Summit
2019-05-22 09:35 am	Dermatology Drug Development Summit
2019-05-22 03:00 am	Dermatology Drug Development Summit - Panel
2019-05-15 06:55 pm	Bank of America Merrill Lynch Health Care Conference
2019-05-07	Q1 2019 Earnings Release
2019-03-13	FY 2018 Earnings Release
2019-03-11 11:20 am	Cowen & Co. Health Care Conference
2019-01-09 02:00 pm	J.P. Morgan Healthcare Conference
2019-01-06 06:20 pm	Dermatology Summit
2018-12-12 10:20 am	BMO Prescriptions for Success Healthcare Conference
2018-07-30 08:15 am	SNA-001 Acne Pivotal Trial Results Call
2018-06-20 08:00 am	JMP Securities Life Sciences Conference
2018-06-06 04:00 pm	Jefferies Global Healthcare Conference
2018-06-01 01:00 pm	Annual General Meeting
2018-05-15 04:40 pm	Bank of America Merrill Lynch Health Care Conference
2018-05-14 09:05 am	Q1 2018 Earnings Release

Fiscal Period	December	2017	2018
Net sales Million USD	Released Forecast Spread	0,00 0,00 -	0,00 0,00 -
EBITDA Million USD	Released Forecast Spread	-48,5 -49,8 2.61%	-76,3 -74,5 -2.47%
EBIT Million USD	Released Forecast Spread	-48,6 -48,5 -0.08%	-76,5 -74,5 -2.68%
Earnings before Tax (EBT) Million USD	Released Forecast Spread	-50,8 -56,7 10.34%	-73,5 -71,0 -3.48%
Net income Million USD	Released Forecast Spread	-50,5 -56,5 10.54%	-73,5 -71,0 -3.48%
EPS USD	Released Forecast Spread	-5,19 -5,72 9.27%	-3,59 -3,49 -2.87%
Announcement Date		15/03/18	14/03/19

2024-07-23	VIKING THERAPEUTICS, INC.: Q2 2024 Earnings Release (Projected)
2024-07-24	BIOCON LIMITED: Q1 2025 Earnings Release (Projected)
2024-07-25 01:00 am	ARGENX SE: Q2 2024 Earnings Release
2024-07-29	RHYTHM PHARMACEUTICALS, INC.: Q2 2024 Earnings Release (Projected)
2024-07-29	NEUROCRINE BIOSCIENCES, INC.: Q2 2024 Earnings Release (Projected)
2024-07-29	CEREVEL THERAPEUTICS HOLDINGS, INC.: Q2 2024 Earnings Release (Projected)
2024-07-30	CASSAVA SCIENCES, INC.: Q2 2024 Earnings Release (Projected)
2024-07-30	SPRINGWORKS THERAPEUTICS, INC.: Q2 2024 Earnings Release (Projected)
2024-07-30	XENCOR, INC.: Q2 2024 Earnings Release (Projected)
2024-07-30	SAREPTA THERAPEUTICS, INC.: Q2 2024 Earnings Release (Projected)

2024-05-17 07:00 am	AUTOLUS THERAPEUTICS PLC: Q1 2024 Earnings Release
2024-05-16 07:46 am	BIOCON LIMITED: Q4 2024 Earnings Release
2024-05-16 01:00 am	ZEALAND PHARMA A/S: Q1 2024 Earnings Release
2024-05-15 08:05 am	THIRD HARMONIC BIO, INC.: Q1 2024 Earnings Release
2024-05-15 07:00 am	CABALETTA BIO, INC.: Q1 2024 Earnings Release
2024-05-14	TAIMED BIOLOGICS INC.: Q1 2024 Earnings Release
2024-05-15 04:01 pm	CELCUITY INC.: Q1 2024 Earnings Release
2024-05-14 04:05 pm	ENLIVEN THERAPEUTICS, INC.: Q1 2024 Earnings Release
2024-05-14 04:00 pm	ARCUTIS BIOTHERAPEUTICS, INC.: Q1 2024 Earnings Release
2024-05-14 08:00 am	IMMUNOME, INC.: Q1 2024 Earnings Release